A PET study to determine biodistribution and binding characteristics of [11C]AZ14132516 in healthy participants

Trial Identifier:	D9690C00003
Sponsor:	AstraZeneca
NCTID::	NCT05818514
Start Date:	May 2023
Primary Completion Date:	September 2023
Study Completion Date:	September 2023
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
SE	Solna, SE, 171 64

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.